Chemoattractant-directed cell migration is critical for the generation and delivery of immune and inflammatory responses 1 . Defining the molecular mechanisms that control directed cell movement is therefore essential for understanding the function of cells of the immune response, the host response to infection and tumors, and immune-mediated autoimmune and inflammatory diseases. Chemokines and other classical chemoattractants, such as formyl-Met-Leu-Phe (fMLP), C5a and leukotriene B 4 , induce directed cell migration through the activation of seven-transmembrane-spanning G protein-coupled receptors 2 . Chemoattractant receptors form a related subfamily of ~50 G proteincoupled receptors that all couple to the pertussis toxin-sensitive cAMPinhibitory heterotrimeric guanine nucleotide-binding protein G i .
A r t i c l e s
Despite the insights noted above, many gaps remain in the understanding of how chemokines and other chemoattractants control this highly integrated multistep process of cell migration. We therefore undertook an RNA-mediated interference (RNAi)-based screen to identify genes previously unknown to be important for chemotaxis. We chose to initially study the effect of gene knockdown on T cell chemotaxis induced by the chemokine CXCL12. CXCL12 and its receptor, CXCR4 (A000636), are essential molecules that direct the migration of essentially all cells, including lymphocytes and hematopoietic stem cells, and are considered to be the primordial chemokine receptor-ligand pair 15, 16 .
RESULTS
To identify genes and pathways required for chemoattractant-induced chemotaxis, we did a lentivirus-based RNAi screen. As our model system, we examined CXCL12-induced, CXCR4-mediated chemotaxis of lymphocytes. We generated short hairpin RNA (shRNA) molecules expressed from lentiviral vectors based on human immunodeficiency virus type 1 and tested their ability to knock down gene expression in lymphocytes. For this, we coinfected SupT1 cells (a human T cell lymphoma line) with lentivirus expressing an shRNA targeting enhanced green fluorescent protein (eGFP) plus lentivirus expressing eGFP and found that eGFP expression was much lower in those cells than in cells coinfected with lentivirus expressing 'scrambled' shRNA and lentivirus expressing eGFP (Supplementary Fig. 1a) .
We then assessed 1,500 arrayed shRNA-encoding viruses obtained from The RNAi Consortium shRNA Library 17 , which targeted 300 genes predominantly but not exclusively encoding kinases and phosphatases, as well as lentiviruses encoding shRNA targeting eGFP, for their ability to affect chemotaxis ( Fig. 1a; targeted genes, Supplementary Table 1) . After infecting and selecting cells, we assessed their ability to migrate to CXCL12 in a Transwell chemotaxis chamber, in a primary screen 18 (Fig. 1a) . By secondary screening we confirmed 11 genes that affected CXCL12-induced migration. These included two genes, SPP1 (encoding osteopontin) and ZAP70 (encoding the tyrosine kinase Zap70), that have been linked before to chemotaxis 19, 20 . Infection with two viruses targeting distinct regions of SPP1 resulted in less migration of SupT1 cells ( Supplementary Fig. 1b,c) . The decrease in SupT1 chemotaxis correlated with the decrease in SPP1 mRNA in infected cells ( Supplementary Fig. 1c,d ). We also identified nine genes previously unknown to influence chemotaxis; these included genes encoding two members of the synaptotagmin family of calcium-dependent regulators of vesicle fusion: SYT2 (A002560), and a related protein, SYTL5. These data demonstrating that synaptotagmins regulate chemotaxis suggested a requirement for vesicle fusion in cell migration and led us to study the role of synaptotagmins in chemotaxis in more detail.
Infection with virus targeting SYTL5 mRNA diminished the ability of SupT1 cells to migrate in response to CXCL12 (Fig. 1b) . This effect correlated with the ability of the shRNA-encoding virus to diminish SYTL5 mRNA expression ( Supplementary Fig. 2a ), which suggested that these results were not due to off-target effects of the shRNA. The knockdown of SYTL5 had no effect on the proliferation of SupT1 cells (Supplementary Fig. 2b ), which demonstrated that the shRNA targeting SYTL5 was not toxic to the cells. To determine if SYTL5 has a similar role in other cells, we used the virus that knocked down its expression in SupT1 cells to infect THP-1 cells (a human monocytic leukemia cell line). Infection with lentivirus encoding shRNA targeting SYTL5 diminished the ability of THP-1 cells to migrate in response to CCL2, the ligand for the chemokine receptor CCR2 (Fig. 1c) . The decrease in SYTL5 protein abundance in SupT1 and THP-1 cells inhibited chemotaxis to different chemokines, which demonstrated that the requirement for SYTL5 in chemotaxis was not limited to one cell type or to one chemokine-chemokine receptor pair.
We also identified another member of the synaptotagmin family, SYT2, in our initial screen. Decreasing the abundance of SYT2 mRNA resulted in enhanced migration of SupT1 cells (Fig. 1b) and THP-1 cells (Fig. 1c) in response to chemokines. The enhanced chemotaxis in SupT1 cells correlated with lower abundance of SYT2 mRNA and SYT2 protein (Fig. 1d-f ). These data demonstrate that SYT2 is a negative regulator of chemotaxis, analogous to its known role as a negative regulator of exocytosis in mast cells 21 .
We then analyzed 14 additional genes encoding synaptotagmin molecules and synaptotagmin-like molecules for their role in chemotaxis by using shRNA targeting each gene in Transwell chemotaxis assays. Only shRNA targeting SYT7, which encodes the lysosomal membrane protein SYT7 (A002565) 22 , a positive regulator of lysosome exocytosis 23 , significantly affected the ability of T cells to migrate in response to CXCL12 (Fig. 1b) . The efficiency of the knockdown of SYT7 mRNA correlated with the decrease in the migration of SupT1 cells to CXCL12 ( Supplementary Fig. 2c,d ). Splenocytes obtained from SYT7-deficient (Syt7 −/− ) mice 24 had less ability to migrate in response to CXCL12 than did splenocytes obtained from wild-type mice ( Fig. 1g) , which confirmed the effect of the SYT7 knockdown. Our findings that SYT7, SYT2 and SYTL5 regulate chemotaxis suggested that vesicle fusion and, in particular, lysosome exocytosis are involved in directed cell migration. To further extend that hypothesis, we used RNAi silencing to analyze genes encoding members of the Rab family of small GTPases that regulate the movement of lysosomes to the membrane for their role in chemotaxis. We chose Rab27a (A001978) because it regulates the exocytosis of secretory lysosomes in cytotoxic T lymphocytes 25 and directly interacts with SYTL5 (ref. 26) . We also selected Rab3a because it interacts with synaptotagmin family members and has an important role in regulated exocytosis 27, 28 . In cells in which expression of RAB27A or RAB3A mRNA was targeted by shRNA, chemotaxis to CXCL12 was markedly inhibited (Fig. 2a) . The lower chemotaxis in SupT1 cells correlated with the decrease in the abundance of RAB27A mRNA and Rab27a protein ( Fig. 2b-d) . The lower chemotaxis in SupT1 cells similarly correlated with the decrease in RAB3A mRNA ( Supplementary  Fig. 2e ). These data demonstrated that the small GTPases Rab27a and Rab3a, proteins known to regulate lysosome exocytosis and interact with synaptotagmins, also have a role in lymphocyte chemotaxis.
To further analyze the migration defect caused by SYT7 deficiency, we obtained bone marrow-derived neutrophils (BMDNs) from Syt7 −/− and wild-type mice and analyzed their ability to migrate in response to the peptide chemoattractant fMLP with a Zigmond chemotaxis chamber 29 and time-lapse video microscopy ( Fig. 3 and Supplementary Movies 1 and 2) . Syt7 −/− BMDNs migrated less than half the distance that wild-type BMDNs migrated (Fig. 3a,b) . The migration velocity of neutrophils obtained from Syt7 −/− mice was significantly less than that of wild-type BMDNs (Fig. 3c) . The diminished chemotaxis was quantitatively similar to the diminshed membrane repair reported for Syt7 −/− cells 24 . SYT7 deficiency also adversely affected the directionality of cell migration (Fig. 3d,e) . Consistent with those findings, polarized Syt7 −/− cells had less prominent lamellopodia than those of wild-type cells ( Supplementary  Movies 1 and 2) , and the extent of cell polarization was less during cell migration (Fig. 3f ). These data demonstrate that SYT7 is a positive regulator of chemotaxis that affects both velocity and directionality in chemoattractant-induced leukocyte migration.
To extend our observations to the in vivo setting, we examined the effect of SYT7 deficiency on the recruitment of neutrophils in a model of gout induced by injection of monosodium urate (MSU) crystals into preformed air pouches on the dorsum of mice [30] [31] [32] . At 8 h after injecting PBS or MSU crystals, we lavaged the air pouches and counted recruited cells and determined the frequency of neutrophils (CD11b + Ly6C + ) and monocytes (CD11b + Ly6C − ) by flow cytometry. The percentage (Fig. 4a ) and absolute number (Fig. 4b) of neutrophils recruited into the air pouch by MSU crystals were much lower in Syt7 −/− mice (recruitment index (MSU/PBS), 4.4) than in wild-type mice (recruitment index, 42.8). As expected, the air pouches of wild-type and Syt7 −/− mice did not have more monocytes (Fig. 4b) . However, at 8 h after MSU crystal injection, we recovered fewer monocytes from air pouches of Syt7 −/− mice, which suggested a recruitment defect for monocytes as well. As this model is dependent on the induction of interleukin 1β (IL-1β) and CXCL2 (MIP-2; ligand for the neutrophil chemokine receptor CXCR2) 
A r t i c l e s
in resident macrophages, we determined the ability of Syt7 −/− macrophages to secrete IL-1β and CXCL2 after being activated with MSU crystals. Peritoneal macrophages derived from wild-type and Syt7 −/− mice showed no difference in their ability to secrete IL-1β or CXCL2 (MIP-2) after being stimulated with MSU crystals (Fig. 4c ) or heat-killed Legionella pneumophilia (data not shown), which demonstrated that the secretion of IL-1β and chemokines was not impaired in SYT7-deficient cells (Fig. 4c ). Together these data demonstrate that SYT7 is required for chemokine-dependent recruitment of neutrophils in vivo.
To begin to explore the mechanism by which synaptotagmin and Rab proteins influence CXCL12-mediated chemotaxis, we determined if knockdown of the genes encoding these molecules affected the surface expression of CXCR4. We infected cell lines with virus expressing shRNA targeting SYTL5, SYT2, SYT7, RAB27A or RAB3A and assessed CXCR4 surface expression and CXCR4 internalization after stimulation with CXCL12 ( Fig. 5a ). There was no significant difference between any of the knockdown cell lines or between Syt7 −/− splenocytes and cells with shRNA-mediated knockdown of eGFP or wild-type cells in their surface expression of CXCR4 (Fig. 5a,b) . Similarly, CXCL12-induced CXCR4 internalization was not significantly altered in any of the knockdown cell lines or in Syt7 −/− cells versus cells with shRNA-mediated knockdown of eGFP or wild-type cells (Fig. 5a,b) .
Actin polymerization is also required for effective directional cell migration 33 . We therefore determined if silencing of SYT7, SYTL5, SYT2, RAB27A or RAB3A affected F-actin polymerization (Fig. 5c) . Knockdown of SYT7, SYT2, RAB27A or RAB3A mediated by shRNA had a minimal effect on chemoattractant-induced F-actin polymerization, as measured by flow cytometry (Fig. 5c) . Splenocytes obtained from Syt7 −/− mice had F-actin polymerization equivalent to that of cells obtained from wild-type mice after stimulation by CXCL12, which confirmed our data obtained with shRNA-mediated knockdown of SYT7 (Fig. 5d) . In contrast, shRNA-mediated knockdown of SYTL5 resulted in less F-actin polymerized after CXCL12 stimulation (Fig. 5c) . Knockdown of SYT7, SYTL5, SYT2 or RAB27A also had no significant effect on calcium release after chemokine stimulation (Fig. 5e) , which demonstrated that the effects of synaptotagmins on chemotaxis are downstream of calcium release.
Because activation of the small GTPases RhoA, Cdc42 and Rac is also critical for cell migration 14 , we studied the effect of SYT7 on chemokine-induced activation of these GTPases. We obtained splenocytes from wild-type and Syt7 −/− mice and analyzed activated RhoA, Cdc42 and Rac in the cells at rest and at 1, 3, 6 and 12 min after stimulation with CXCL12 (Fig. 5f ). CXCL2 induced equivalent activation profiles for these GTPases in cells obtained Syt7 −/− mice and wild-type mice (Fig. 5f) , which demonstrated that SYT7 is not directly involved in GTPase activation after chemokine stimulation.
Synaptotagmin proteins contain calcium-sensing domains that mediate their role in calcium-dependent vesicle fusion 22 . As a transient increase in intracellular free calcium is a hallmark of chemoattractant receptor activation, it is possible that synaptotagmins have a similar role in mediating calcium-dependent vesicle fusion after chemoattractant stimulation, which may also be required for chemotaxis. To begin to test this, we first studied the effect of the intracellular calcium chelator BAPTA on chemokine-induced calcium flux and chemotaxis. As expected, BAPTA blocked calcium influx after chemokine stimulation (Fig. 5e) . BAPTA also completely inhibited the migration of SupT1 cells and Jurkat cells (a human T cell leukemia line) to CXCL12 (Fig. 6a and Supplementary Fig. 3a) . In contrast, BAPTA had no effect on chemokine-induced polymerization of F-actin ( Fig. 6b and Supplementary Fig. 3b) , which suggested that an increase in intracellular free calcium is required for chemotaxis but is not required for F-actin polymerization. SYT7 (ref. 22) and Rab27a 34 are known positive regulators of lysosome exocytosis, whereas SYT2 (ref. 21 ) is a known negative regulator of lysosome exocytosis. We therefore investigated whether stimulation with chemoattractants induced calcium-dependent lysosome fusion and exocytosis. To determine if stimulation with chemoattractants results in the fusion of lysosomes with the cell membrane, we analyzed expression of the lysosomal marker LAMP-1 on the surface of BMDNs after stimulation with the chemoattractant C5a (Fig. 6c) . Cell-surface expression of LAMP-1 was markedly enhanced after C5a stimulation (Fig. 6c) . Consistent with those findings, extracellular β-hexosaminidase activity increased after the addition of fMLP to HL-60 human promyelocytic leukemia cells (Supplementary Fig. 4) , which demonstrated that chemoattractants induce lysosome-cell membrane fusion that results in the release of lysosomal contents into the extracellular milieu. Similar to its effect on chemotaxis, BAPTA resulted in much lower chemoattractant-induced expression of LAMP-1 on the cell surface (Fig. 6c) . These data demonstrate that chemoattractant stimulation results in calcium-dependent fusion of LAMP-1 + vesicles with the cell membrane.
We next tested the effect of SYT7 deficiency on chemoattractantinduced cell surface expression of LAMP-1. Neutrophils derived from wild-type and Syt7 −/− mice had similar basal surface expression of LAMP-1 (Fig. 6d) . However, the induction of cell surface expression of LAMP-1 after C5a stimulation was markedly attenuated in Syt7 −/− neutrophils compared with that in wild-type neutrophils (Fig. 6d) . To localize chemokine-induced lysosome fusion, we imaged podocytes, which are 40 times larger than leukocytes. Podocytes express the chemokine receptor CXCR3 (ref. 35 ) and have been shown to migrate in response to chemokines 36 . We stimulated podocytes with the CXCR3 ligand CXCL11 and found that the lysosomal markers cathepsin-L and LAMP-2 localized to the plasma membrane (Fig. 6e) , which demonstrated again that chemokine stimulation results in the fusion of lysosomes with the cell membrane. Together these data suggest that synaptotagmins function downstream of chemoattractant-induced calcium release and upstream of the fusion of LAMP-1 + vesicles with the plasma membrane.
To visualize the role of SYT7 in vesicle localization during chemotaxis, we used laser-scanning confocal microscopy to analyze activated wild-type and Syt7 −/− CD4 + T cells migrating in a CXCL10 gradient (Fig. 7a) . We used the red fluorescent dye LysoTracker Red to visualize intracellular vesicles with a low pH, including lysosomes. Migrating Syt7 −/− T cells had much more accumulation of LysoTracker Red in the distal ends of their uropods (Fig. 7a and Supplementary  Movies 3-6) . To quantify the accumulation of LysoTracker Red, we sampled fluorescence intensity of cell bodies and uropods of polarized cells and then normalized those results to cell area. The cell bodies of polarized wild-type and Syt7 −/− lymphocytes had a similar area, whereas the uropods of Syt7 −/− lymphocytes were marginally smaller than those of wild-type lymphocytes (Fig. 7b) . Syt7 −/− T cells showed A r t i c l e s twofold greater LysoTracker Red fluorescence across the cell body and over fourfold greater normalized intensity in the uropod than that of wild-type cells (Fig. 7c) . The accumulation of LysoTracker Red-stained vesicles in Syt7 −/− lymphocytes is consistent with less fusion of these vesicles with the cell membrane than that of migrating wild-type lymphocytes. In addition, the ratio of uropod to cellbody fluorescence intensity was twice as high in polarized Syt7 −/− cells as in polarized wild-type cells (Fig. 7d) , which demonstrated that LysoTracker Red-stained vesicles were distributed differently in Syt7 −/− cells exposed to a chemokine gradient.
Coincident with the accumulation of LysoTracker Red described above, uropods in Syt7 −/− T cells seemed to have difficulty releasing from the substrate, which resulted in cells that seemed to be stuck in place by a tethered tail (Fig. 7e and Supplementary Movies 3-6) . Over the 30 min of observation, 6.14% of polarized wild-type T cells (7 of 114) demonstrated an adherent phenotype, whereas 81.48% of polarized Syt7 −/− T cells (88 of 108) demonstrated an adherent phenotype (Fig. 7f) . Furthermore, comparison of the average time of adherence of wild-type and Syt7 −/− T cells with the adherent phenotype at their uropods showed that Syt7 −/− T cells had an average adherence time of 29.43 ± 0.36 min, whereas for the wild-type cells it was 20.46 ± 3.76 min (Fig. 7g) . Thus, the few wild-type T cells with the adhesion phenotype had a shorter duration period of adhesion, whereas the majority of Syt7 −/− T cells remained adherent at their uropods for the duration of the 30-minute observation period. The phenotype we observed for the impaired migration of Syt7 −/− neutrophils and T cells suggests a previously unknown role for synaptogamins and calcium-dependent vesicle fusion in the de-adhesion process required for cell migration.
DISCUSSION
In an RNAi-based genetic screen to identify genes encoding molecules that function in leukocyte chemotaxis, we have identified genes encoding molecules known to regulate vesicle trafficking and fusion. We found that three genes in the synaptotagmin family encoding calcium-sensing membrane proteins regulated chemoattractantinduced directed cell migration. We identified SYT7 and the related protein SYTL5 as positive regulators of chemotaxis, whereas we found SYT2 to be a negative regulator of chemotaxis. Those findings are consistent with the opposing roles of these proteins in regulating calciumdependent lysosomal exocytosis 21, 22 . We also identified Rab27a and Rab3a, small GTPases that regulate lysosome transport and interact with the synaptotagmin proteins identified 37 , as positive regulators of chemotaxis. We used SYT7-deficient mice to further characterize the role of SYT7 in cell migration. Neutrophils derived from those mice migrated more slowly and with less directionality than did neutrophils derived from wild-type mice. Furthermore, SYT7-deficient mice showed a neutrophil recruitment defect in an in vivo model of MSU crystal-induced gout, even though SYT7-deficient and wildtype macrophages secreted equivalent amounts of IL-1β and CXCL12 (MIP-2) in response to MSU crystals. Exploring the mechanism by which synaptotagmins influence chemotaxis, we found that SYT7 as well as calcium flux were required for chemoattractant-induced cell surface expression of LAMP-1. By confocal video imaging of lymphocytes migrating in a chemokine gradient, we observed that LysoTracker Red-stained vesicles accumulated in the uropods of the SYT7-deficient cells, which also suggested that SYT7 mediates chemokine-induced fusion of lysosomes with the cell membrane in migrating cells. Furthermore, we found that SYT7 was required for effective de-adhesion and uropod detachment. Collectively, our data identify a molecular pathway required for chemotaxis mediated by synaptotagmins and Rab proteins that involves chemoattractantinduced vesicle exocytosis and uropod release.
The idea that membrane flow and vesicle trafficking have a role in cell migration has been considered for many years. In 1962 it was suggested that there is a membrane cycle during cell migration; experiments showed that 100-nM beads move around the cell surface during cell migration 38 . Later it was shown that membrane flows toward the rear of the migrating cell and caps at the front of the cell [39] [40] [41] . In 1983 further evidence for vesicle trafficking during cell migration was presented showing that the surface of the HeLa human cervical cancer cell becomes rough during cell movement, thus suggesting membrane recycling 42 . Subsequently, it has been shown that lipids move to the front, whereas proteins move to the rear, of migrating cells 43 . Consistent with that, in 1994 it was shown that recycling receptors in endocytic vesicles are routed to the plasma membrane of the leading lamella of migrating chick fibroblasts 44 . These descriptive studies all suggested that vesicle trafficking occurs during cell migration, but they did not explore the molecular mechanisms that mediate this process or demonstrate the functional importance of vesicle trafficking in cell migration. We have now done both by defining a role for several proteins (SYT7, SYTL5, SYT2, Rab27a and Rab3a) in a pathway that controls vesicle trafficking in chemotaxis and, using STY7-deficient mice, we have demonstrated that this process is important for chemotaxis in vitro and for cell migration in vivo.
Exploring the mechanism by which synaptotagmin and Rab proteins influence chemotaxis, we found that chemokine receptor abundance and chemokine-induced receptor internalization were not affected by knockdown of SYT7, SYTL5, SYT2, RAB27A or RAB3A. Our findings differ from those of a study that found that another synaptotagmin, SYT3, regulates recycling and surface expression of CXCR4 in the TAM2D2 mouse T cell line 45 . This suggests that the role of SYT3 may be different from that of the synaptotagmins identified in our study. In addition, we also found that chemokineinduced polymerization of F-actin and calcium flux were not affected by knockdown of SYT7, SYT2, RAB27A or RAB3A. Knockdown of SYTL5, however, resulted in less F-actin polymerization after chemokine stimulation, which suggests that this synaptotagmin-like protein may have an effect on cells distinct from that of the other synaptotagmins studied. Together these findings suggested that synaptotagmins participate in chemotaxis downstream of the expression of chemoattractant receptors and initial signal transduction. Given the known function of synaptotagmins in mediating calcium-induced fusion of vesicles with the cell membrane, we suspected that synaptotagmins may have a similar role in chemoattractant-induced chemotaxis.
Ins(1,4,5)P 3 , generated via chemoattractant receptor activation of PLC, is thought to induce the increase in intracellular free calcium by activating Ins(1,4,5)P 3 receptors on the endoplasmic reticulum, which then open up calcium channels, resulting in the release of free calcium into the cytoplasm. In migrating cells, calcium is thought to contribute to many processes, including directional sensing, cytoskeleton redistribution (through effects on myosin light-chain kinase or calmodulin kinase, among others), traction force regeneration and the relocation of focal adhesions 3,4,9,10 . Additionally, it has been suggested that calcium is important for uropod release in migrating neutrophils 46 . However, an absolute requirement for calcium flux in cell migration has been controversial. PLC-β2 and PLC-β3 are the two main PLC isoforms found in leukocytes, and neutrophils obtained from mice doubly deficient in PLC-β2 and PLC-β3 have a blunted calcium flux and enhanced migration compared with that of wild-type neutrophils, which suggests that calcium may not be required for chemotaxis 47 . In contrast, lymphocytes obtained from mice doubly deficient in PLC-β2 and PLC-β3 have no calcium flux and much less chemotaxis 48 , which suggests that PLC-β2 and PLC-β3 are required for calcium flux and chemotaxis in lymphocytes but not in neutrophils, in which other PLC isoforms may also contribute to localized calcium influx and chemotaxis. Similar to results obtained in our experiments with BAPTA, lymphocyte chemotaxis has been shown to be inhibited by calcium chelation 48 . Notably, we found that calcium chelation also inhibited the chemotaxis of Jurkat T cells, even though a detectable calcium flux is not typically evident in these cells after chemokine stimulation. It is likely that calcium is required at specific intracellular microdomains during chemotaxis 49 that may not always be appreciated in a wholecell calcium-efflux assay.
As mentioned above, the identification of synaptotagmin family members in our RNAi screen suggested that chemokine-induced release of calcium may induce the fusion of vesicles with the cell membrane and this may in turn be required for effective chemotaxis. Synaptotagmin family members, including SYT7, SYT2 and SYTL5, contain calcium-sensing domains that are critical for the regulation of calcium-induced vesicle fusion 23 . We therefore sought to determine if chemoattractant-induced calcium flux has a role in synaptotagmin-mediated vesicle fusion during chemotaxis. In support of our hypothesis, we found that chemoattractants induced cell surface expression of LAMP-1, which suggested that chemoattractant receptor signaling can induce the fusion of lysosomes with the cell surface. We also found that this process required both calcium and SYT7, which suggests that calcium-induced vesicle fusion contributes to effective chemotaxis. This result is consistent with the observation that VAMP-7, a SYT7-regulated SNARE protein required for calciumdependent fusion of lysosomes with the cell membrane, has a role in epithelial cell migration 50 .
We also used live-cell video microscopy of LysoTracker Red-labeled wild-type and SYT7-deficient lymphocytes migrating in a chemokine gradient to visualize the movement of lysosomes in migrating lymphocytes. Although we were unable to visualize the movement of individual vesicles with this technique, we found that LysoTracker Red-stained vesicles accumulated to a greater extent in the uropods of SYT7-deficient cells than in those of wild-type cells. This phenotype was consistent with the failure of lysosome-cell membrane fusion in SYT7-deficient cells. We also unexpectedly found that SYT7-deficient cells had difficulty releasing uropods and had prolonged attachment to the substrate. This phenotype was reminiscent of that of neutrophils treated with a calcium chelator 46 . Uropod release and de-adhesion are active regulated processes required for effective cell migration. De-adhesion is a calcium-dependent process that requires activity of the RhoA kinase ROCK and nonmuscle myosin heavy chain IIA in the uropod 46, [51] [52] [53] . Our data suggest that SYT7-dependent fusion of intracellular vesicles with the cell membrane may be required for the delivery of cargo important for the detachment of uropods from the substrate. The delivered cargo may be proteins known to accumulate in the uropods of migrating cells or phospholipids required for the cell membrane dynamics associated with uropod release. The identification of these factors awaits further investigation.
Of potential clinical relevance to our study, Chediak-Higashi syndrome is a congenital immunodeficiency that results from a mutation in LYST (encoding the lysosomal trafficking regulator LYST) 54 . Neutrophils obtained from patients with this syndrome have impaired function, including defective chemotaxis. Our study raises the possibility that the impaired neutrophil chemotaxis seen in Chediak-Higashi syndrome may be a direct consequence of a defect in lysosomal transport. Our data showing that SYT7-deficient cells had impaired chemotaxis ex vivo and cell migration in vivo demonstrate that chemokine-induced vesicle transport and fusion pathways are important in leukocyte migration.
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/. Purification of BMDNs. BMDNs were purified as reported 56 . Marrow cavities of the tibias and femurs of 8-week-old mice were flushed with complete DMEM containing 10% (vol/vol) FCS. After hypotonic lysis of red blood cells, mature neutrophils were isolated by centrifugation for 30 min at 28 °C and 500g over discontinuous Percoll gradients consisting of 55% (vol/vol), 65% (vol/vol) and 75% (vol/vol) Percoll in PBS. Mature neutrophils were recovered at the interface of the 65% and 75% fractions. Neutrophil purity varied between 70% and 90%. CD4 + T lymphocyte purification and activation. CD4 + T lymphocytes were purified from spleens obtained from wild-type and Syt7 −/− mice by magnetic bead separation according to the manufacturer's instructions (DynalInvitrogen). Cells (5 × 10 5 ) were plated in 1 ml complete RPMI medium containing 10% (vol/vol) FCS and anti-CD28 (1:1,000 dilution; 37.51; 553294; BD Pharmingen) on plates coated with anti-CD3 (2 μg/ml; 145-2C11; 553057; BD Pharmingen). On day 3, cells were provided complete RPMI medium containing IL-2 (5 ng/ml). Cells were analyzed on days 6-10.
ONLINE METhODS
Splenocyte purification. Spleens were isolated from wild-type or Syt7 −/− mice. Individual cell suspensions were obtained by disruption of spleens in RPMI medium, followed by passage through a 70-μm cell strainer. Cells were spun for 7 min at 470g and the resulting cell suspensions were subjected to hypotonic lysis of red blood cells. Cells were washed twice, then resuspended in complete RPMI medium with 10% (vol/vol) FCS and assayed the next day.
Syt7 −/− mice. Syt7 −/− mice on the C57BL/6 background were generated as reported 24 . C57BL/6 mice were obtained from the National Center for Biotechnology Information. All mice were bred and used at Massachusetts General Hospital under protocols approved by the Subcommittees on Research and Animal Care.
Lentivirus production. Plasmids encoding lentiviruses expressing shRNA molecules were obtained from The RNAi Consortium shRNA Library 57 . Plasmids were purified with a QIAprep Miniprep kit (Qiagen). Plasmids were then transfected into HEK293T cells by a three-plasmid system for the production of lentivirus 57,58 .
Lentivirus infection and selection. Cells were placed in 96-well tissue culture dishes (2 × 10 4 cells per well) and were infected with 5 μl unconcentrated shRNA lentiviral supernatant and polybrene (7.5 μg/ml). Cells were spun for 30 min at 830g and were incubated for 4 d. Infected cells were selected in complete RPMI medium containing 10% (vol/vol) FBS and puromycin (3 μg/ml) and were tested 2 weeks after infection.
Transwell chemotaxis assay. Chemotaxis was assayed in 96-well chemotaxis chambers with polycarbonate membranes (pore size, 5 μm; Neuroprobe) as reported 18 . CyQUANT dye mix (Molecular Probes-Invitrogen) was used for quantification of migrating cells as reported 18 . After 2 h of incubation, fluorescence was measured in a CytoFluor fluorescent plate reader (Applied Biosystems). Primary cell chemotaxis was measured by flow cytometry. Migrating cells were placed into a flow cytometry tube containing 20,000 1-μm latex beads (Invitrogen). Events were collected until 4,000 beads were accumulated and the number of cells per 4,000 beads was obtained. The statistical significance of chemotaxis data was determined by ANOVA.
For the primary screen, the number of cells infected with each arrayed virus was determined with Alamar Blue according to the manufacturer's directions (US Biological). CXCL12 was placed in the bottom well of a Neuroprobe chemotaxis chamber (10 nM per well). Cells were spun (100 μl, containing on average 4 × 10 4 cells), then were resuspended in 50 μl chemotaxis buffer and placed on top of the filter in the chemotaxis chamber. After 3 h of incubation, the number of cells migrating to the lower chamber was determined with CyQUANT. The chemotactic index was determined by division of the number of migrating cells (as determined by CyQUANT fluorescence) by the number of input cells (as determined by Alamar Blue fluorescence) and the results were normalized to 1 on the basis of the migration of cells expressing eGFPspecific shRNA. The mean and s.d. of chemotactic indices for all infected cell lines on each plate was determined. Genes were selected for further study if two or more shRNAs targeting the gene changed the chemotactic index of the infected cells by approximately 1 or more s.d. in the same direction. For the secondary screen, after selection in puromycin, cells were counted in a hemocytometer and their ability to migrate to CXCL12 in a Neuroprobe chemotaxis chamber was tested. Cells (2.5 × 10 4 ) were placed on top of the filter on the chamber. RPMI medium with 1% (wt/vol) BSA was placed in the bottom well of the chamber with 0, 1, 10 or 100 nM CXCL12. Migration of cells to the lower chamber was quantified with CyQUANT and compared with that of cells infected with viruses expressing eGFP-specific shRNA. Gene identifiers and shRNA target sequences are in Supplementary Table 2.
Quantitative PCR. Total RNA obtained with the RNeasy kit (Qiagen) was treated with DNase I (Invitrogen). Total RNA (10-50 ng) was used as a template for the reverse-transcription reaction; 50 μl cDNA was synthesized with oligo(dT) 15 , random hexamers, and MultiScribe reverse transcriptase (Applied Biosystems). All reactions used the same conditions and the same reverse-transcription master mix to minimize differences in reverse-transcription efficiency. Quantitative PCR used 5 μl cDNA, 12.5 μl 2× SYBR Green master mix (Stratagene) and 250 nmol sense and antisense primers. Oligonucleotide primer sequences designed on the PrimerBank website 59 and obtained from Integrated DNA Technologies were as follows: SYTL5, 5′-ATGATCCTGGGCGTCCTAAAG-3′ and 5′-TCCCACTTCTACGTTTTGCTTC-3′; SYT2, 5′ -TCCCTGGACTAT GATTTTCAGGC-3′ and 5′-GTCTTCCGATGGACTTTGGTC-3′; SYT7, 5′-ACTGGTGTCAGCGCAAACT-3′ and 5′-GCAGGCAACTTGATAGCC TTCT-3′; Rab3a, 5′-AAGACCATCTATCGCAACGACA-3′ and 5′-CCATAGC GCCCCGGTAGTA-3′; and Rab27a, 5′-GAAACTGGATAAGCCAGCTA CAG-3′ and 5′-ATATTTCTCTGCGAGTGCTATGG-3′. Emitted fluorescence for each reaction was measured three times during the annealing-extension phase, and amplification plots were analyzed with MX4000 software, version 3.0 (Stratagene). The quantity of gene expression was generated by comparison of the fluorescence generated by each sample with standard curves of known quantities, and the calculated number of copies was divided by the number of copies of the housekeeping genes GAPDH and B2M (encoding β 2 -microglobulin).
Immunoblot analysis. Cellular extracts were prepared with Nonidet P-40 buffer (150 mM NaCl, 1% (vol/vol) Nonidet P-40 and 50 mM Tris, pH 8) and Complete Protease Inhibitors (Roche). After separation by PAGE, proteins were transferred to nitrocellulose membranes. Anti-SYT2 (ab68854; Abcam) and anti-Rab27a (ab55567; Abcam) were added at a dilution of 1:1,000 in a solution of 1% (wt/vol) dehydrated milk in Tris-buffered saline with 0.05% (vol/vol) Tween-20. Analysis of β-actin served as a loading control; anti-β-actin (AC-15; ab6276; Abcam) was added to the blots at a dilution of 1:10,000 in a solution of 1% (wt/vol) dehydrated milk in Tris-buffered saline with 0.05% (vol/vol) Tween-20. Blots were developed with ECL Plus reagents (GE Healthcare).
Video migration assays. BMDNs were seeded on coverslips (4 × 10 4 cells each) and then were placed on a Zigmond chemotaxis chamber (Neuroprobe). Either fMLP or CXCL1 (KC; data not shown), at a concentration of 100 nM in 1% (wt/vol) BSA, was placed in the right well of the Zigmond chamber and RPMI medium with 1% (wt/vol) BSA was added to the left well. After a 5-minute equilibration period, brightfield images were obtained every 15 s for 30 min with a SPOT charge-coupled device camera controlled by SPOT software. Stacks of images were analyzed by ImageJ software (National Institutes of Health) with the chemotaxis plug-in for analysis of the track, velocity and direction of each moving cell (Ibidi).
